Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 47, 2021 - Issue 4
Submit an article Journal homepage
638
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use

Kirsten E. Smitha National Institute on Drug Abuse Intramural Research Program, Translational Addiction Medicine Branch, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8352-3688View further author information
ORCID Icon,
Jeffery M. Rogersa National Institute on Drug Abuse Intramural Research Program, Translational Addiction Medicine Branch, Baltimore, MD, USAView further author information
,
Justin C. Stricklandb Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0003-1077-0394View further author information
ORCID Icon &
David H. Epsteina National Institute on Drug Abuse Intramural Research Program, Translational Addiction Medicine Branch, Baltimore, MD, USAView further author information
Pages 455-466 | Received 16 Jan 2021, Accepted 13 Mar 2021, Published online: 28 Apr 2021

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, Charles A. Veltri, Stephanie T. Weiss, Charles M. White & Oliver Grundmann. (2024) An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations. Expert Review of Clinical Pharmacology 17:2, pages 131-142.
Read now
Salma Pont-Fernandez, Marina Kheyfets, Jeffrey M. Rogers, Kirsten E. Smith & David H. Epstein. (2023) Kava (Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects. The American Journal of Drug and Alcohol Abuse 49:1, pages 85-96.
Read now
Oliver Grundmann, Charles A. Veltri, Diana Morcos, David Knightes$suffix/text()$suffix/text(), Kirsten E. Smith & Jeffery M. Rogers. (2022) How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data. Substance Abuse 43:1, pages 865-877.
Read now
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, Oliver Grundmann, Christopher R. McCurdy, Albert Garcia-Romeu, Destiny Schriefer, Marc T. Swogger & David H. Epstein. (2022) Kratom use as more than a “self-treatment”. The American Journal of Drug and Alcohol Abuse 48:6, pages 684-694.
Read now
Kirsten E. Smith, Jeffrey M. Rogers & Justin C. Strickland. (2022) Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample. Journal of Psychoactive Drugs 54:5, pages 429-439.
Read now
William Rushton & Jessica Rivera. (2021) Tianeptine: a new frontier in surveillance and understanding through social media. The American Journal of Drug and Alcohol Abuse 47:4, pages 411-413.
Read now
Varun Y. Rawal, Matthew Gallardo, Katelyn Henderson, Orman Trent Hall, Nicholas Klisovic & Eleonora Sikic-Klisovic. Severe tianeptine withdrawal symptoms managed with medications for opioid use disorder: a case report. Journal of Addictive Diseases 0:0, pages 1-6.
Read now

Articles from other publishers (13)

Yu Chi & Huai-yu Chen. (2023) Investigating Substance Use via Reddit: Systematic Scoping Review. Journal of Medical Internet Research 25, pages e48905.
Crossref
Amber N. Edinoff, Saveen Sall, Scott P. Beckman, Andrew D. Koepnick, Logan C. Gold, Eric D. Jackson, Danielle M. Wenger, Elyse M. Cornett, Kevin S. Murnane, Adam M. Kaye & Alan D. Kaye. (2023) Tianeptine, an Antidepressant with Opioid Agonist Effects: Pharmacology and Abuse Potential, a Narrative Review. Pain and Therapy 12:5, pages 1121-1134.
Crossref
Jared T. Seale, Emily A. Garden, John M. T. French & Owen M. McDougal. (2023) Analysis of Tianeptine in Dietary Supplements. Nutraceuticals 3:3, pages 481-488.
Crossref
Morgan L Wagner, Joseph Pergolizzi, Jo Ann K LeQuang, Frank Breve & Giustino Varrassi. (2023) From Antidepressant Tianeptine to Street Drug ZaZa: A Narrative Review. Cureus.
Crossref
Yoseph B. Kale & Gayatri Bhatia. (2023) Tianeptine misuse- Emerging evidence from India. Psychiatry Research Case Reports 2:1, pages 100108.
Crossref
Kirsten Elin Smith, Jeffrey M. Rogers & Jeffrey D. Feldman. (2023) Kratom’s Emergence and Persistence Within the US Polydrug Epidemic. Current Addiction Reports 10:2, pages 262-271.
Crossref
Jennifer L. Hargett, Presly F. Lowry & Keyshawnna N. Lee. (2023) Nursing Implications for Tianeptine Use and Misuse. Journal of Addictions Nursing 34:2, pages 158-161.
Crossref
Laura Szczesniak & Ross Sullivan. (2022) Microdose Induction of Buprenorphine in a Patient Using Tianeptine. Journal of Addiction Medicine 16:6, pages 736-738.
Crossref
Brayden Kameg. (2022) Tianeptine. Journal of Addictions Nursing 33:4, pages 331-332.
Crossref
T. R. Baird, H. I. Akbarali, W. L. Dewey, H. Elder, M. Kang, S. A. Marsh, M. R. Peace, J. L. Poklis, E. J. Santos & S. S. Negus. (2022) Opioid-like adverse effects of tianeptine in male rats and mice. Psychopharmacology 239:7, pages 2187-2199.
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, Oliver Grundmann, Christopher R. McCurdy, Destiny Schriefer & David H. Epstein. (2022) Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in Pharmacology 13.
Crossref
Jeffrey M Rogers, Kirsten E Smith, Destiny Schriefer & David H Epstein. (2022) For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic. Substance Abuse: Research and Treatment 16, pages 117822182211239.
Crossref
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland & David H. Epstein. (2021) Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample. Frontiers in Pharmacology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.